Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	15.02B -39.1%
Revenue (ttm)	15.69B +3.8%
Net Income	1.59B -30.0%
EPS	0.35 -30.3%
Shares Out	4.54B
PE Ratio	9.56
Forward PE	8.24
Dividend	0.18 (5.57%)
Ex-Dividend Date	Oct 21, 2026

Volume	6,625,917
Open	3.325
Previous Close	3.350
Day's Range	3.295 - 3.345
52-Week Range	2.920 - 5.820
Beta	0.32
Analysts	Buy
Price Target	4.97 (+50.03%)
Est. Earnings	Nov 18, 2026

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1988
• Employees: 13,310
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2025, HKG:1066's revenue was 13.39 billion, an increase of 2.31% compared to the previous year's 13.09 billion. Earnings were 1.61 billion, a decrease of -21.99%.

Financial numbers in CNY

Analyst Summary

According to 9 analysts, the average rating for 1066 stock is "Buy." The 12-month stock price target is $4.97, which is an increase of 50.03% from the latest price.

Price Target

$4.97

(50.03% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error